Clinical proof of concept study (blossom) shows novel beta 3 adrenoceptor agonist YM178 is effective and well tolerated in the treatment of symptoms of overactive bladder

Research output: Contribution to journalPublished meeting abstract


  • C R Chapple
  • O Yamaguchi
  • A Ridder
  • J Liehne
  • S Carl
  • Anders Mattiasson
  • M A L Arambunu
  • M Lucas
  • K Everaert
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Urology and Nephrology
Original languageEnglish
Pages (from-to)239-239
JournalEuropean Urology Supplements
Issue number3
Publication statusPublished - 2008
Publication categoryResearch
Event23rd Annual Congress of the European Association of Urology, 2008 - Milan, Italy
Duration: 2008 Mar 262008 Mar 29
Conference number: 23